For my 22‑month‑old daughter and 3½‑year‑old son with high‑risk TB exposure, can an interferon‑γ release assay (IGRA) replace the tuberculin skin test (TST) for latent tuberculosis screening?

TST is Preferred for Your Young Children, But IGRA is Acceptable

For your 22-month-old daughter and 3½-year-old son with high-risk TB exposure, the tuberculin skin test (TST) remains the preferred screening method, though IGRA is an acceptable alternative. 1, 2

Why TST is Preferred in Children Under 5 Years

The CDC explicitly states that TST is preferred for testing children aged <5 years 1. This preference exists because:

• Limited data on IGRA performance in very young children – Most guidelines acknowledge insufficient evidence for IGRA sensitivity and reliability in this age group 3, 4, 5
• Higher indeterminate rates – Children have significantly higher rates of indeterminate IGRA results (OR = 2.56), which increases as age decreases 6
• Young children are at highest risk for progression to severe TB disease – The 22-month-old is in the highest-risk category where missing infection could be catastrophic 4, 2

The High-Risk Context Changes the Equation

Because both children have high-risk TB exposure (close contact with active TB), some experts advocate using BOTH tests together to maximize sensitivity 3, 4. The rationale:

• Canada recommends both TST and IGRA for high-risk contacts 3
• The TBNET consensus suggests that "if either test gives a positive result, this may be regarded as supportive evidence of infection, and the children should be offered preventive chemotherapy" 4
• Young children with exposure to sputum smear-positive TB should receive prophylaxis regardless of initial test results 4

Practical Algorithm for Your Situation

For the 22-month-old:

1. Start TST as the primary test
2. Consider adding IGRA to increase sensitivity (not to replace TST)
3. If TST is negative initially, start prophylaxis anyway and retest in 3 months – children <5 years with high-risk exposure should receive treatment independent of test results 4

For the 3½-year-old:

1. TST remains preferred, but IGRA is more acceptable at this age
2. Either test alone is reasonable, or both together for maximum sensitivity
3. Same 3-month retest protocol if initially negative

Critical Pitfalls to Avoid

• Do not delay treatment waiting for test results – In high-risk exposures, especially for the 22-month-old, prophylaxis should begin immediately after excluding active TB disease 4
• Do not rely solely on a single negative test – Window period testing at 8-10 weeks post-exposure is essential 1
• BCG vaccination status is irrelevant for your decision – Both children are at high risk from documented exposure, making specificity concerns secondary to sensitivity 3, 4

The Bottom Line

While IGRA can technically be used instead of TST at any age per CDC guidelines 1, the weight of evidence strongly favors TST for children under 5 years, particularly your 22-month-old 1, 2. The 2017 ATS/IDSA/CDC guidelines extended IGRA recommendations down to age 5 years specifically because children ≥5 years have immune responses equivalent to adults, implicitly acknowledging limitations below this age 2.

For your specific situation with documented high-risk exposure, the safest approach is TST as the primary test, with consideration of adding IGRA (not replacing) to maximize detection, and initiating prophylaxis promptly regardless of initial test results 4.